Science & Technology
Science and Technology
Science and Technology
Fri, April 3, 2009
Thu, April 2, 2009
Mediware Information Systems: Addition of New Distribution Agreement Expands Market Potential for Mediware's Ascend Pharmacy So
LENEXA, KS--(Marketwire - April 2, 2009) - Mediware Information Systems, Inc. (
"We are very pleased to be aligned with IntraNexus through this channel relationship and look forward to increased product penetration and growth," said Thomas Mann, Mediware's president and chief executive officer. "There is a clear trend in mid market hospitals for adopting integrated, hospital-wide technology platforms. With the advantage of advanced web-based technologies and faster implementations, we believe the combination of these products and technologies provides the market a cost-effective alternative to the large vendors."
IntraNexus, which has provided a broad array of software and consulting services for healthcare institutions since 1991, launched the SAPPHIRE health management platform as a competitive alternative to the integrated systems offered by large vendors. SAPPHIRE, which is completely web-based and open technology, includes software modules that span the entire healthcare enterprise to provide hospitals an integrated electronic medical record to coordinate patient care, admissions, discharges and billing.
"I'm very pleased to have an agreement with Mediware to add the Ascend pharmacy solution to our overall SAPPHIRE architecture," said Rick O'Pry, IntraNexus' founder and chief executive officer. "Customer satisfaction is our top priority, so the quality of the product -- and the company that stands behind the product -- are very important to us. I look forward to introducing this system to our customers and prospects."
The new relationship with Mediware provides IntraNexus a proven software system to manage the complex clinical requirements of hospital pharmacies. The relationship is also advantageous for Mediware as it expands the company's channel sales potential and market reach.
"Channel relationships such as this provide Mediware a cost-effective sales strategy for many of our products," said Mr. Mann. "Through IntraNexus, we have the ability to supplement our direct sales efforts for the Ascend product, expand our market penetration and provide customers a level of collaboration they desire. We are very encouraged by all we have learned about their product, positioning and potential."
The Ascend pharmacy system was part of Mediware's recent acquisition of [ Hann's On Software (HOS) ], a transaction that was previously announced on November 21, 2008. Ascend is in use by more than 320 customers in the United States.
[ About Mediware ]
Mediware delivers blood and medication management software systems that encapsulate information supporting patient therapies, reinforce patient safety practices and improve efficiencies to lower costs. Mediware's customers include prestigious hospitals, clinics, correctional institutions, blood centers and other public and private health care institutions throughout the world. For more information about Mediware products and services, visit our web site, [ www.mediware.com ].
[ About Intranexus ]
IntraNexus was established in 1992 and is dedicated to improving efficiencies in healthcare through technology solutions. For more than 16 years, IntraNexus has delivered comprehensive consulting services in conjunction with the SAPPHIRE HIS. Our high-quality, cost-effective solutions have positioned us as a leader in development, implementation and support of the SAPPHIRE suite of applications. The SAPPHIRE Server and SAPPHIRE Web solutions can support patient access, revenue cycle, and advanced clinical needs for healthcare organizations. For more information visit [ http://www.intranexus.com ] or call 888-815-0095. Visit IntraNexus at HIMSS09 at Booth 7824.
Certain statements in this press release may constitute "forward-looking" statements within the meaning of the Private Securities Litigation Reform Act of 1995, as the same may be amended from time to time (the "Act") and in releases made by the SEC from time to time. Such forward-looking statements are not based on historical facts and involve known and unknown risks, uncertainties and other factors disclosed in the Company's Annual Report on Form 10-K for the year ended June 30, 2008, which may cause the actual results of the Company to be materially different from any future results expressed or implied by such forward-looking statements. The Company disclaims any obligation to update its forward-looking statements.
